Characterization of the Purified Hyaluronan Synthase from Streptococcus equisimilis

Hyaluronan synthase (HAS) utilizes UDP-GlcUA and UDP-GlcNAc in the presence of Mg2+ to form the GAG hyaluronan (HA). The purified HAS from Streptococcus equisimilis (seHAS) shows high fidelity in that it only polymerizes the native substrates, UDP-GlcNAc and UDP-GlcUA. However, other uridinyl nucleo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemistry (Easton) 2004-07, Vol.43 (28), p.9234-9242
Hauptverfasser: Tlapak-Simmons, Valarie L, Baron, Christina A, Weigel, Paul H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 9242
container_issue 28
container_start_page 9234
container_title Biochemistry (Easton)
container_volume 43
creator Tlapak-Simmons, Valarie L
Baron, Christina A
Weigel, Paul H
description Hyaluronan synthase (HAS) utilizes UDP-GlcUA and UDP-GlcNAc in the presence of Mg2+ to form the GAG hyaluronan (HA). The purified HAS from Streptococcus equisimilis (seHAS) shows high fidelity in that it only polymerizes the native substrates, UDP-GlcNAc and UDP-GlcUA. However, other uridinyl nucleotides and UDP-sugars inhibited enzyme activity, including UDP-GalNAc, UDP-Glc, UDP-Gal, UDP-GalUA, UMP, UDP, and UTP. Purified seHAS was ∼40% more active in 25 mM, compared to 50 mM, PO4 in the presence of either 50 mM NaCl or KCl, and displayed a slight preference for KCl over NaCl. The pH profile was surprisingly broad, with an effective range of pH 6.5−11.5 and the optimum between pH 9 and 10. SeHAS displayed two apparent pK a values at pH 6.6 and 11.8. As the pH was increased from ∼6.5, both K m and V max increased until pH ∼ 10.5, above which the kinetic constants gradually declined. Nonetheless, the overall catalytic constant (120/s) was essentially unchanged from pH 6.5 to 10.5. The enzyme is temperature labile, but more stable in the presence of substrate and cardiolipin. Purified seHAS requires exogenous cardiolipin for activity and is very sensitive to the fatty acyl composition of the phospholipid. The enzyme was inactive or highly activated by synthetic cardiolipins containing, respectively, C14:0 or C18:1(Δ9) fatty acids. The apparent E act for HA synthesis is 40 kJ (9.5 kcal/mol) disaccharide. Increasing the viscosity by increasing concentrations of PEG, ethylene glycol, glycerol, or sucrose inhibited seHAS activity. For PEGs, the extent of inhibition was proportional to their molecular mass. PEGs with average masses of 2.7, 11.7, and 20 kg/mol caused 50% inhibition of V max at 21, 6.5, and 3.5 mM, respectively. The apparent K i values for ethylene glycol, glycerol, and sucrose were, respectively, 4.5, 3.3, and 1.2 mM.
doi_str_mv 10.1021/bi049468v
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1586113</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66700976</sourcerecordid><originalsourceid>FETCH-LOGICAL-a536t-984d20a55aa7b6be3c4d67d049d12d24b7647c163d3a2c2f19cfeacb5e51e5563</originalsourceid><addsrcrecordid>eNqFkU9rFEEQxRtRzBo9-AVkLgoeRrt7-s_MRZAlMYaAwY0iXpqanhq348z0prsnuH56O-yyKgieiqJ-vHpVj5CnjL5ilLPXraOiEaq-vUcWTHJaiqaR98mCUqpK3ih6RB7FeJ1bQbV4SI4yJGpdswVZLdcQwCYM7ick56fC90VaY3E5B9c77IqzLQxz8BNMxWo7pTVELPrgx2KVAm6St97aORZ4M7voRje4-Jg86GGI-GRfj8mn05Or5Vl58eHd--XbixJkpVLZ1KLjFKQE0K1qsbKiU7rLp3SMd1y0Wgltmaq6CrjlPWtsj2BbiZKhlKo6Jm92upu5HbGzOKUAg9kEN0LYGg_O_D2Z3Np887eGyVoxVmWBF3uB4G9mjMmMLlocBpjQz9EopSlttPovyBpeZ7cygy93oA0-xoD9wQ2j5i4rc8gqs8_-tP-b3IeTgXIHuJjwx2EO4btRutLSXF2uzNcvTH1einPzMfPPdzzYaK79HKb8_X8s_gXF1qz-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19287645</pqid></control><display><type>article</type><title>Characterization of the Purified Hyaluronan Synthase from Streptococcus equisimilis</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Tlapak-Simmons, Valarie L ; Baron, Christina A ; Weigel, Paul H</creator><creatorcontrib>Tlapak-Simmons, Valarie L ; Baron, Christina A ; Weigel, Paul H</creatorcontrib><description>Hyaluronan synthase (HAS) utilizes UDP-GlcUA and UDP-GlcNAc in the presence of Mg2+ to form the GAG hyaluronan (HA). The purified HAS from Streptococcus equisimilis (seHAS) shows high fidelity in that it only polymerizes the native substrates, UDP-GlcNAc and UDP-GlcUA. However, other uridinyl nucleotides and UDP-sugars inhibited enzyme activity, including UDP-GalNAc, UDP-Glc, UDP-Gal, UDP-GalUA, UMP, UDP, and UTP. Purified seHAS was ∼40% more active in 25 mM, compared to 50 mM, PO4 in the presence of either 50 mM NaCl or KCl, and displayed a slight preference for KCl over NaCl. The pH profile was surprisingly broad, with an effective range of pH 6.5−11.5 and the optimum between pH 9 and 10. SeHAS displayed two apparent pK a values at pH 6.6 and 11.8. As the pH was increased from ∼6.5, both K m and V max increased until pH ∼ 10.5, above which the kinetic constants gradually declined. Nonetheless, the overall catalytic constant (120/s) was essentially unchanged from pH 6.5 to 10.5. The enzyme is temperature labile, but more stable in the presence of substrate and cardiolipin. Purified seHAS requires exogenous cardiolipin for activity and is very sensitive to the fatty acyl composition of the phospholipid. The enzyme was inactive or highly activated by synthetic cardiolipins containing, respectively, C14:0 or C18:1(Δ9) fatty acids. The apparent E act for HA synthesis is 40 kJ (9.5 kcal/mol) disaccharide. Increasing the viscosity by increasing concentrations of PEG, ethylene glycol, glycerol, or sucrose inhibited seHAS activity. For PEGs, the extent of inhibition was proportional to their molecular mass. PEGs with average masses of 2.7, 11.7, and 20 kg/mol caused 50% inhibition of V max at 21, 6.5, and 3.5 mM, respectively. The apparent K i values for ethylene glycol, glycerol, and sucrose were, respectively, 4.5, 3.3, and 1.2 mM.</description><identifier>ISSN: 0006-2960</identifier><identifier>EISSN: 1520-4995</identifier><identifier>DOI: 10.1021/bi049468v</identifier><identifier>PMID: 15248781</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Cardiolipins - pharmacology ; Enzyme Stability ; Glucuronosyltransferase ; Hyaluronan Synthases ; Hydrogen-Ion Concentration ; Kinetics ; Potassium Chloride - pharmacology ; Sodium Chloride - pharmacology ; Streptococcus equi - enzymology ; Streptococcus equisimilis ; Substrate Specificity ; Temperature ; Transferases - chemistry ; Transferases - isolation &amp; purification ; Transferases - metabolism ; Viscosity</subject><ispartof>Biochemistry (Easton), 2004-07, Vol.43 (28), p.9234-9242</ispartof><rights>Copyright © 2004 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a536t-984d20a55aa7b6be3c4d67d049d12d24b7647c163d3a2c2f19cfeacb5e51e5563</citedby><cites>FETCH-LOGICAL-a536t-984d20a55aa7b6be3c4d67d049d12d24b7647c163d3a2c2f19cfeacb5e51e5563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/bi049468v$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/bi049468v$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,780,784,885,2763,27074,27922,27923,56736,56786</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15248781$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tlapak-Simmons, Valarie L</creatorcontrib><creatorcontrib>Baron, Christina A</creatorcontrib><creatorcontrib>Weigel, Paul H</creatorcontrib><title>Characterization of the Purified Hyaluronan Synthase from Streptococcus equisimilis</title><title>Biochemistry (Easton)</title><addtitle>Biochemistry</addtitle><description>Hyaluronan synthase (HAS) utilizes UDP-GlcUA and UDP-GlcNAc in the presence of Mg2+ to form the GAG hyaluronan (HA). The purified HAS from Streptococcus equisimilis (seHAS) shows high fidelity in that it only polymerizes the native substrates, UDP-GlcNAc and UDP-GlcUA. However, other uridinyl nucleotides and UDP-sugars inhibited enzyme activity, including UDP-GalNAc, UDP-Glc, UDP-Gal, UDP-GalUA, UMP, UDP, and UTP. Purified seHAS was ∼40% more active in 25 mM, compared to 50 mM, PO4 in the presence of either 50 mM NaCl or KCl, and displayed a slight preference for KCl over NaCl. The pH profile was surprisingly broad, with an effective range of pH 6.5−11.5 and the optimum between pH 9 and 10. SeHAS displayed two apparent pK a values at pH 6.6 and 11.8. As the pH was increased from ∼6.5, both K m and V max increased until pH ∼ 10.5, above which the kinetic constants gradually declined. Nonetheless, the overall catalytic constant (120/s) was essentially unchanged from pH 6.5 to 10.5. The enzyme is temperature labile, but more stable in the presence of substrate and cardiolipin. Purified seHAS requires exogenous cardiolipin for activity and is very sensitive to the fatty acyl composition of the phospholipid. The enzyme was inactive or highly activated by synthetic cardiolipins containing, respectively, C14:0 or C18:1(Δ9) fatty acids. The apparent E act for HA synthesis is 40 kJ (9.5 kcal/mol) disaccharide. Increasing the viscosity by increasing concentrations of PEG, ethylene glycol, glycerol, or sucrose inhibited seHAS activity. For PEGs, the extent of inhibition was proportional to their molecular mass. PEGs with average masses of 2.7, 11.7, and 20 kg/mol caused 50% inhibition of V max at 21, 6.5, and 3.5 mM, respectively. The apparent K i values for ethylene glycol, glycerol, and sucrose were, respectively, 4.5, 3.3, and 1.2 mM.</description><subject>Cardiolipins - pharmacology</subject><subject>Enzyme Stability</subject><subject>Glucuronosyltransferase</subject><subject>Hyaluronan Synthases</subject><subject>Hydrogen-Ion Concentration</subject><subject>Kinetics</subject><subject>Potassium Chloride - pharmacology</subject><subject>Sodium Chloride - pharmacology</subject><subject>Streptococcus equi - enzymology</subject><subject>Streptococcus equisimilis</subject><subject>Substrate Specificity</subject><subject>Temperature</subject><subject>Transferases - chemistry</subject><subject>Transferases - isolation &amp; purification</subject><subject>Transferases - metabolism</subject><subject>Viscosity</subject><issn>0006-2960</issn><issn>1520-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9rFEEQxRtRzBo9-AVkLgoeRrt7-s_MRZAlMYaAwY0iXpqanhq348z0prsnuH56O-yyKgieiqJ-vHpVj5CnjL5ilLPXraOiEaq-vUcWTHJaiqaR98mCUqpK3ih6RB7FeJ1bQbV4SI4yJGpdswVZLdcQwCYM7ick56fC90VaY3E5B9c77IqzLQxz8BNMxWo7pTVELPrgx2KVAm6St97aORZ4M7voRje4-Jg86GGI-GRfj8mn05Or5Vl58eHd--XbixJkpVLZ1KLjFKQE0K1qsbKiU7rLp3SMd1y0Wgltmaq6CrjlPWtsj2BbiZKhlKo6Jm92upu5HbGzOKUAg9kEN0LYGg_O_D2Z3Np887eGyVoxVmWBF3uB4G9mjMmMLlocBpjQz9EopSlttPovyBpeZ7cygy93oA0-xoD9wQ2j5i4rc8gqs8_-tP-b3IeTgXIHuJjwx2EO4btRutLSXF2uzNcvTH1einPzMfPPdzzYaK79HKb8_X8s_gXF1qz-</recordid><startdate>20040720</startdate><enddate>20040720</enddate><creator>Tlapak-Simmons, Valarie L</creator><creator>Baron, Christina A</creator><creator>Weigel, Paul H</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20040720</creationdate><title>Characterization of the Purified Hyaluronan Synthase from Streptococcus equisimilis</title><author>Tlapak-Simmons, Valarie L ; Baron, Christina A ; Weigel, Paul H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a536t-984d20a55aa7b6be3c4d67d049d12d24b7647c163d3a2c2f19cfeacb5e51e5563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Cardiolipins - pharmacology</topic><topic>Enzyme Stability</topic><topic>Glucuronosyltransferase</topic><topic>Hyaluronan Synthases</topic><topic>Hydrogen-Ion Concentration</topic><topic>Kinetics</topic><topic>Potassium Chloride - pharmacology</topic><topic>Sodium Chloride - pharmacology</topic><topic>Streptococcus equi - enzymology</topic><topic>Streptococcus equisimilis</topic><topic>Substrate Specificity</topic><topic>Temperature</topic><topic>Transferases - chemistry</topic><topic>Transferases - isolation &amp; purification</topic><topic>Transferases - metabolism</topic><topic>Viscosity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tlapak-Simmons, Valarie L</creatorcontrib><creatorcontrib>Baron, Christina A</creatorcontrib><creatorcontrib>Weigel, Paul H</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Biochemistry (Easton)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tlapak-Simmons, Valarie L</au><au>Baron, Christina A</au><au>Weigel, Paul H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of the Purified Hyaluronan Synthase from Streptococcus equisimilis</atitle><jtitle>Biochemistry (Easton)</jtitle><addtitle>Biochemistry</addtitle><date>2004-07-20</date><risdate>2004</risdate><volume>43</volume><issue>28</issue><spage>9234</spage><epage>9242</epage><pages>9234-9242</pages><issn>0006-2960</issn><eissn>1520-4995</eissn><abstract>Hyaluronan synthase (HAS) utilizes UDP-GlcUA and UDP-GlcNAc in the presence of Mg2+ to form the GAG hyaluronan (HA). The purified HAS from Streptococcus equisimilis (seHAS) shows high fidelity in that it only polymerizes the native substrates, UDP-GlcNAc and UDP-GlcUA. However, other uridinyl nucleotides and UDP-sugars inhibited enzyme activity, including UDP-GalNAc, UDP-Glc, UDP-Gal, UDP-GalUA, UMP, UDP, and UTP. Purified seHAS was ∼40% more active in 25 mM, compared to 50 mM, PO4 in the presence of either 50 mM NaCl or KCl, and displayed a slight preference for KCl over NaCl. The pH profile was surprisingly broad, with an effective range of pH 6.5−11.5 and the optimum between pH 9 and 10. SeHAS displayed two apparent pK a values at pH 6.6 and 11.8. As the pH was increased from ∼6.5, both K m and V max increased until pH ∼ 10.5, above which the kinetic constants gradually declined. Nonetheless, the overall catalytic constant (120/s) was essentially unchanged from pH 6.5 to 10.5. The enzyme is temperature labile, but more stable in the presence of substrate and cardiolipin. Purified seHAS requires exogenous cardiolipin for activity and is very sensitive to the fatty acyl composition of the phospholipid. The enzyme was inactive or highly activated by synthetic cardiolipins containing, respectively, C14:0 or C18:1(Δ9) fatty acids. The apparent E act for HA synthesis is 40 kJ (9.5 kcal/mol) disaccharide. Increasing the viscosity by increasing concentrations of PEG, ethylene glycol, glycerol, or sucrose inhibited seHAS activity. For PEGs, the extent of inhibition was proportional to their molecular mass. PEGs with average masses of 2.7, 11.7, and 20 kg/mol caused 50% inhibition of V max at 21, 6.5, and 3.5 mM, respectively. The apparent K i values for ethylene glycol, glycerol, and sucrose were, respectively, 4.5, 3.3, and 1.2 mM.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>15248781</pmid><doi>10.1021/bi049468v</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-2960
ispartof Biochemistry (Easton), 2004-07, Vol.43 (28), p.9234-9242
issn 0006-2960
1520-4995
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1586113
source MEDLINE; American Chemical Society Journals
subjects Cardiolipins - pharmacology
Enzyme Stability
Glucuronosyltransferase
Hyaluronan Synthases
Hydrogen-Ion Concentration
Kinetics
Potassium Chloride - pharmacology
Sodium Chloride - pharmacology
Streptococcus equi - enzymology
Streptococcus equisimilis
Substrate Specificity
Temperature
Transferases - chemistry
Transferases - isolation & purification
Transferases - metabolism
Viscosity
title Characterization of the Purified Hyaluronan Synthase from Streptococcus equisimilis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T06%3A43%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20the%20Purified%20Hyaluronan%20Synthase%20from%20Streptococcus%20equisimilis&rft.jtitle=Biochemistry%20(Easton)&rft.au=Tlapak-Simmons,%20Valarie%20L&rft.date=2004-07-20&rft.volume=43&rft.issue=28&rft.spage=9234&rft.epage=9242&rft.pages=9234-9242&rft.issn=0006-2960&rft.eissn=1520-4995&rft_id=info:doi/10.1021/bi049468v&rft_dat=%3Cproquest_pubme%3E66700976%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19287645&rft_id=info:pmid/15248781&rfr_iscdi=true